Evidence map›Paper›PMID 33738161›Full record

ArticleCureus2021

Association of Gastrointestinal System With Severity and Mortality of COVID-19: A Systematic Review and Meta-Analysis.

Trishala Menon, Rohit Sharma, Geethika Earthineni, Hanan Iftikhar, Manush Sondhi, Saad Shams, Noman Khurshid Ahmed, Hira Khan, Sawai Singh Rathore, Romil Singh

Abstract read
In one paragraph

Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Review
  12. The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Article
  13. Article
  14. Article
  15. Frequency and outcomes of gastrointestinal symptoms in patients with Corona Virus Disease-19.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2021
    Article
  16. Review
  17. Article
  18. A Comprehensive Meta-Analysis of COVID-19 in Latin America.SOJ microbiology & infectious diseases · 2021
    Article
  19. Gastrointestinal manifestations of COVID-19 in a single center in the Eastern Province of Saudi Arabia.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association
    Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Trishala MenonFamily Medicine, Wheeling Hospital, Wheeling, USA.
Rohit SharmaInternal Medicine, Hamad Medical Corporation, Doha, QAT.
Geethika EarthineniInternal Medicine, Sri Devaraj Urs Medical College, Kolar, IND.
Hanan IftikharInternal Medicine, Foundation University Medical College, Islamabad, PAK.
Manush SondhiInternal Medicine, Kasturba Medical College, Manipal, IND.
Saad ShamsInternal Medicine, Ross University School of Medicine, Florida, USA.
Noman Khurshid AhmedMedicine, Dow Medical College, Dow University of Health Sciences, Karachi, PAK.
Hira KhanInternal Medicine, Islamic International Medical College, Rawalpindi, PAK.
Sawai Singh RathoreInternal Medicine, Dr Sampurnanand Medical College, Jodhpur, IND.
Romil SinghCritical Care, Mayo Clinic, Rochester, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At present, the novel coronavirus disease (COVID-19) is causing a major pandemic. COVID-19 is caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). In COVID-19, the patient usually presents with fever, dry cough, and respiratory manifestations. However, the involvement of other systems has also been reported in the literature. Abdominal pain, diarrhea, vomiting, and nausea are the predominant gastrointestinal (GI) manifestations underlined in the literature. We conducted a literature search using four databases (PubMed, Web of Science, Google Scholar, and Clinicaltrials.gov). Our search strategy included Medical Subject Headings (MeSH) terms and keywords for COVID-19, SARS-CoV-2, and GI system from inception to October 2020. After excluding duplicates, review articles, and non-relevant articles, we included 20 studies out of 842 articles reporting GI manifestations in COVID-19 patients. Using Cochrane RevMan version 5.4 (Cochrane, London, UK), a compute pooled analysis using a random-effect model was performed. Our study included 6,022 patients with a median age of 49.5 years. Pooled analysis via random effect model revealed an increased risk of severe COVID-19 in patients manifesting GI symptoms with an odds ratio (OR) of 2.07 (95% Confidence Interval [CI]: 1.34-3.18) with I

Indexed as

covid-19gastrointestinal manifestationshepatic manifestationssars-cov-2

Identifiers

PMID33738161
PMCPMC7957843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.